Core Insights - The article highlights the increasing prevalence of asthma globally, with over 358 million patients and an expected rise to over 400 million this year, particularly affecting children in China, where over 45 million are affected, including 15 million children [1][2] Group 1: Asthma in Children - Asthma is a common chronic disease among children, often triggered by allergens such as dust mites, pet dander, and certain foods, as well as environmental factors like cold air and vigorous exercise [3][4] - The condition is characterized by bronchial spasms leading to breathing difficulties, with a noted increase in cases due to allergies and viral respiratory infections [3][4] - While asthma cannot be cured, various treatment methods, including inhalation therapy and traditional Chinese medicine, can help manage symptoms and improve quality of life [3][4] Group 2: Asthma in Adults - Adult asthma can present atypically, with symptoms such as chronic cough and nighttime chest tightness, which may be mistaken for common colds [5][6] - Many adults may have experienced asthma symptoms in childhood, which can resurface in adulthood if not properly managed, potentially leading to chronic obstructive pulmonary disease (COPD) [6][7] - Older adults face higher asthma prevalence, often complicated by other chronic conditions, making treatment more challenging and increasing the risk of multi-organ damage [6][7]

5月6日是第二十七个"世界防治哮喘日"，今年的主题是"让吸入疗法惠及所有哮喘患者"。 正确认识吸入性药物 提高哮喘控制率 哮喘是最常见的慢性疾病，被世界卫生组织列为疾病中四大顽症之一。数据显示，全球哮喘患者的数量约为2.6亿，其中死亡病例约为43.6万例。在我国，20 岁及以上人群的哮喘患病率为4.2%，约有4570万哮喘患者。 专家介绍，如果规范治疗，哮喘可以得到控制。但由于认识不足，超过80%的患者都因暂停用药而导致疾病失控。 华中科技大学附属同济医院呼吸内科主任医师 刘辉国：吸入性治疗是哮喘病人治疗的核心， 所以今年世界哮喘日里面就提到一个口号， 让吸入性治疗惠及 所有的哮喘患者。这个也进一步说明了哮喘病人应该尽量采用吸入治疗，药物可以直接进入到呼吸的气道，而对全身的副作用轻很多，所以吸入治疗是慢性 气道疾病非常重要的一环。 专家介绍，我国城区哮喘总体控制率为28.58%，相比一些发达国家40%～50%的控制率，仍有较大差距。这主要因为不少人对哮喘药物，尤其是吸入性药物 有误解。有的人认为，激素类药物无法根治哮喘，还会导致发胖、股骨头坏死等症状，那干脆就不用药了！ 实际上，治疗哮喘使用的吸入性药物中，糖 ...